CalciMedica is trading at $0.81 (8.6% up) in after-hours as it partially rebounds from a sharp 25.7% drop during the August 3 regular session.
- The move follows a two-day FDA-driven rally on July 30–31 and appears linked to ongoing trading and profit-taking dynamics rather than fresh news.
- The current price action reflects a technical correction as the market continues to digest recent regulatory optimism and subsequent volatility.